This report studies the global Therapeutic Nuclear Medicines market status and forecast, categorizes the global Therapeutic Nuclear Medicines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
In 2017, the global Therapeutic Nuclear Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.
The major manufacturers covered in this report
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
IBA Molecular Imaging
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Beta Emitters
Alpha Emitters
Brachytherapy Products
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Others
The study objectives of this report are:
To analyze and study the global Therapeutic Nuclear Medicines sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Therapeutic Nuclear Medicines manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Therapeutic Nuclear Medicines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Therapeutic Nuclear Medicines Manufacturers
Therapeutic Nuclear Medicines Distributors/Traders/Wholesalers
Therapeutic Nuclear Medicines Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Therapeutic Nuclear Medicines market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Global Therapeutic Nuclear Medicines Market Research Report 2018
1 Therapeutic Nuclear Medicines Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Therapeutic Nuclear Medicines Segment by Type (Product Category)
1.2.1 Global Therapeutic Nuclear Medicines Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Therapeutic Nuclear Medicines Production Market Share by Type (Product Category) in 2017
1.2.3 Beta Emitters
1.2.4 Alpha Emitters
1.2.5 Brachytherapy Products
1.3 Global Therapeutic Nuclear Medicines Segment by Application
1.3.1 Therapeutic Nuclear Medicines Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Endocrine Tumors
1.3.6 Others
1.4 Global Therapeutic Nuclear Medicines Market by Region (2013-2025)
1.4.1 Global Therapeutic Nuclear Medicines Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 Asia-Pacific Status and Prospect (2013-2025)
1.4.5 South America Status and Prospect (2013-2025)
1.4.6 Middle East & Africa Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Therapeutic Nuclear Medicines (2013-2025)
1.5.1 Global Therapeutic Nuclear Medicines Revenue Status and Outlook (2013-2025)
1.5.2 Global Therapeutic Nuclear Medicines Capacity, Production Status and Outlook (2013-2025)
2 Global Therapeutic Nuclear Medicines Market Competition by Manufacturers
2.1 Global Therapeutic Nuclear Medicines Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Therapeutic Nuclear Medicines Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Therapeutic Nuclear Medicines Production and Share by Manufacturers (2013-2018)
2.2 Global Therapeutic Nuclear Medicines Revenue and Share by Manufacturers (2013-2018)
2.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Therapeutic Nuclear Medicines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
2.5.1 Therapeutic Nuclear Medicines Market Concentration Rate
2.5.2 Therapeutic Nuclear Medicines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Therapeutic Nuclear Medicines Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Therapeutic Nuclear Medicines Capacity and Market Share by Region (2013-2018)
3.2 Global Therapeutic Nuclear Medicines Production and Market Share by Region (2013-2018)
3.3 Global Therapeutic Nuclear Medicines Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 Asia-Pacific Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 South America Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Middle East & Africa Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Therapeutic Nuclear Medicines Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Therapeutic Nuclear Medicines Consumption by Region (2013-2018)
4.2 North America Therapeutic Nuclear Medicines Production, Consumption, Export, Import (2013-2018)
4.3 Europe Therapeutic Nuclear Medicines Production, Consumption, Export, Import (2013-2018)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Production, Consumption, Export, Import (2013-2018)
4.5 South America Therapeutic Nuclear Medicines Production, Consumption, Export, Import (2013-2018)
4.6 Middle East & Africa Therapeutic Nuclear Medicines Production, Consumption, Export, Import (2013-2018)
5 Global Therapeutic Nuclear Medicines Production, Revenue (Value), Price Trend by Type
5.1 Global Therapeutic Nuclear Medicines Production and Market Share by Type (2013-2018)
5.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2013-2018)
5.3 Global Therapeutic Nuclear Medicines Price by Type (2013-2018)
5.4 Global Therapeutic Nuclear Medicines Production Growth by Type (2013-2018)
6 Global Therapeutic Nuclear Medicines Market Analysis by Application
6.1 Global Therapeutic Nuclear Medicines Consumption and Market Share by Application (2013-2018)
6.2 Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Therapeutic Nuclear Medicines Manufacturers Profiles/Analysis
7.1 Cardinal Health
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Cardinal Health Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Mallinckrodt
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Mallinckrodt Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 GE Healthcare
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 GE Healthcare Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Lantheus Medical Imaging
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Bayer
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Bayer Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Bracco Imaging
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Bracco Imaging Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Eczacibasi-Monrol Nuclear Products
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Nordion
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Nordion Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Advanced Accelerator Applications
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Advanced Accelerator Applications Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 IBA Molecular Imaging
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
8 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
8.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Therapeutic Nuclear Medicines Market Forecast (2018-2025)
12.1 Global Therapeutic Nuclear Medicines Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Therapeutic Nuclear Medicines Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Therapeutic Nuclear Medicines Price and Trend Forecast (2018-2025)
12.2 Global Therapeutic Nuclear Medicines Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Therapeutic Nuclear Medicines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Therapeutic Nuclear Medicines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 Asia-Pacific Therapeutic Nuclear Medicines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 South America Therapeutic Nuclear Medicines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Middle East & Africa Therapeutic Nuclear Medicines Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Therapeutic Nuclear Medicines Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Therapeutic Nuclear Medicines
Figure Global Therapeutic Nuclear Medicines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Therapeutic Nuclear Medicines Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Beta Emitters
Table Major Manufacturers of Beta Emitters
Figure Product Picture of Alpha Emitters
Table Major Manufacturers of Alpha Emitters
Figure Product Picture of Brachytherapy Products
Table Major Manufacturers of Brachytherapy Products
Figure Global Therapeutic Nuclear Medicines Consumption (K Units) by Applications (2013-2025)
Figure Global Therapeutic Nuclear Medicines Consumption Market Share by Applications in 2017
Figure Thyroid Examples
Table Key Downstream Customer in Thyroid
Figure Bone Metastasis Examples
Table Key Downstream Customer in Bone Metastasis
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Endocrine Tumors Examples
Table Key Downstream Customer in Endocrine Tumors
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Therapeutic Nuclear Medicines Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure South America Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East & Africa Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Therapeutic Nuclear Medicines Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Therapeutic Nuclear Medicines Major Players Product Capacity (K Units) (2013-2018)
Table Global Therapeutic Nuclear Medicines Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Therapeutic Nuclear Medicines Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Therapeutic Nuclear Medicines Capacity (K Units) of Key Manufacturers in 2017
Figure Global Therapeutic Nuclear Medicines Capacity (K Units) of Key Manufacturers in 2018
Figure Global Therapeutic Nuclear Medicines Major Players Product Production (K Units) (2013-2018)
Table Global Therapeutic Nuclear Medicines Production (K Units) of Key Manufacturers (2013-2018)
Table Global Therapeutic Nuclear Medicines Production Share by Manufacturers (2013-2018)
Figure 2017 Therapeutic Nuclear Medicines Production Share by Manufacturers
Figure 2017 Therapeutic Nuclear Medicines Production Share by Manufacturers
Figure Global Therapeutic Nuclear Medicines Major Players Product Revenue (Million USD) (2013-2018)
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers
Table 2018 Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers
Table Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area
Table Manufacturers Therapeutic Nuclear Medicines Product Category
Figure Therapeutic Nuclear Medicines Market Share of Top 3 Manufacturers
Figure Therapeutic Nuclear Medicines Market Share of Top 5 Manufacturers
Table Global Therapeutic Nuclear Medicines Capacity (K Units) by Region (2013-2018)
Figure Global Therapeutic Nuclear Medicines Capacity Market Share by Region (2013-2018)
Figure Global Therapeutic Nuclear Medicines Capacity Market Share by Region (2013-2018)
Figure 2017 Global Therapeutic Nuclear Medicines Capacity Market Share by Region
Table Global Therapeutic Nuclear Medicines Production by Region (2013-2018)
Figure Global Therapeutic Nuclear Medicines Production (K Units) by Region (2013-2018)
Figure Global Therapeutic Nuclear Medicines Production Market Share by Region (2013-2018)
Figure 2017 Global Therapeutic Nuclear Medicines Production Market Share by Region
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) by Region (2013-2018)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2013-2018)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2013-2018)
Table 2017 Global Therapeutic Nuclear Medicines Revenue Market Share by Region
Figure Global Therapeutic Nuclear Medicines Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table South America Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Middle East & Africa Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Therapeutic Nuclear Medicines Consumption (K Units) Market by Region (2013-2018)
Table Global Therapeutic Nuclear Medicines Consumption Market Share by Region (2013-2018)
Figure Global Therapeutic Nuclear Medicines Consumption Market Share by Region (2013-2018)
Figure 2017 Global Therapeutic Nuclear Medicines Consumption (K Units) Market Share by Region
Table North America Therapeutic Nuclear Medicines Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Therapeutic Nuclear Medicines Production, Consumption, Import & Export (K Units) (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Production, Consumption, Import & Export (K Units) (2013-2018)
Table South America Therapeutic Nuclear Medicines Production, Consumption, Import & Export (K Units) (2013-2018)
Table Middle East & Africa Therapeutic Nuclear Medicines Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Therapeutic Nuclear Medicines Production (K Units) by Type (2013-2018)
Table Global Therapeutic Nuclear Medicines Production Share by Type (2013-2018)
Figure Production Market Share of Therapeutic Nuclear Medicines by Type (2013-2018)
Figure 2017 Production Market Share of Therapeutic Nuclear Medicines by Type
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) by Type (2013-2018)
Table Global Therapeutic Nuclear Medicines Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Therapeutic Nuclear Medicines by Type (2013-2018)
Figure 2017 Revenue Market Share of Therapeutic Nuclear Medicines by Type
Table Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2013-2018)
Figure Global Therapeutic Nuclear Medicines Production Growth by Type (2013-2018)
Table Global Therapeutic Nuclear Medicines Consumption (K Units) by Application (2013-2018)
Table Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2013-2018)
Figure Global Therapeutic Nuclear Medicines Consumption Market Share by Applications (2013-2018)
Figure Global Therapeutic Nuclear Medicines Consumption Market Share by Application in 2017
Table Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2013-2018)
Figure Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2013-2018)
Table Cardinal Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cardinal Health Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cardinal Health Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure Cardinal Health Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mallinckrodt Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mallinckrodt Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure Mallinckrodt Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure Mallinckrodt Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GE Healthcare Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure GE Healthcare Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table Lantheus Medical Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure Bayer Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure Bayer Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table Bracco Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bracco Imaging Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bracco Imaging Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure Bracco Imaging Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure Bracco Imaging Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table Eczacibasi-Monrol Nuclear Products Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table Nordion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nordion Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Nordion Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure Nordion Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure Nordion Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table Advanced Accelerator Applications Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Advanced Accelerator Applications Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table IBA Molecular Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Production Growth Rate (2013-2018)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Production Market Share (2013-2018)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2017
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure Global Therapeutic Nuclear Medicines Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Therapeutic Nuclear Medicines Price (Million USD) and Trend Forecast (2018-2025)
Table Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Region (2018-2025)
Figure Global Therapeutic Nuclear Medicines Production Market Share Forecast by Region (2018-2025)
Table Global Therapeutic Nuclear Medicines Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Region (2018-2025)
Figure North America Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Therapeutic Nuclear Medicines Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Therapeutic Nuclear Medicines Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Therapeutic Nuclear Medicines Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure South America Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2018-2025)
Figure South America Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table South America Therapeutic Nuclear Medicines Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Middle East & Africa Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Middle East & Africa Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Middle East & Africa Therapeutic Nuclear Medicines Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Type (2018-2025)
Figure Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Type (2018-2025)
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2018-2025)
Table Global Therapeutic Nuclear Medicines Price Forecast by Type (2018-2025)
Table Global Therapeutic Nuclear Medicines Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Therapeutic Nuclear Medicines Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
+1 888 709 8757
Chat With Us